A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Cost-Effectiveness Analysis of Nintedanib in Idiopathic Pulmonary Fibrosis in the UK
Authors
Keywords
Overall Survival, National Health Service, Idiopathic Pulmonary Fibrosis, Force Vital Capacity, Acute Exacerbation
Journal
PHARMACOECONOMICS
Volume 35, Issue 4, Pages 479-491
Publisher
Springer Nature
Online
2016-12-31
DOI
10.1007/s40273-016-0480-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of idiopathic pulmonary fibrosis: a network meta-analysis
- (2016) Bram Rochwerg et al. BMC Medicine
- Drug Treatment of Idiopathic Pulmonary Fibrosis
- (2016) William J. Canestaro et al. CHEST
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
- (2015) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Principles for consistent value assessment and sustainable funding of orphan drugs in Europe
- (2015) Laura Gutierrez et al. Orphanet Journal of Rare Diseases
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
- (2013) Brett Ley et al. ANNALS OF INTERNAL MEDICINE
- Treating Idiopathic Pulmonary Fibrosis with the Addition of Co-Trimoxazole: An Economic Evaluation Alongside a Randomised Controlled Trial
- (2013) Edward C. F. Wilson et al. PHARMACOECONOMICS
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
- (2013) D. Husereau et al. BMJ-British Medical Journal
- Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
- (2012) Wills Hughes-Wilson et al. Orphanet Journal of Rare Diseases
- Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis
- (2012) SAKAE HOMMA et al. RESPIROLOGY
- Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial
- (2012) Ludmila Shulgina et al. THORAX
- Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
- (2011) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
- (2011) Roland M. du Bois et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Lung Transplant in Idiopathic Pulmonary Fibrosis
- (2011) Timothy J. George ARCHIVES OF SURGERY
- Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium
- (2011) Steven D. Nathan et al. CHEST
- Severity classification for idiopathic pulmonary fibrosis by using fuzzy logic
- (2011) Agnaldo José Lopes et al. Clinics
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using Health State Utility Values from the General Population to Approximate Baselines in Decision Analytic Models when Condition-Specific Data are Not Available
- (2011) Roberta Ara et al. VALUE IN HEALTH
- Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
- (2009) C. J. Zappala et al. EUROPEAN RESPIRATORY JOURNAL
- Pirfenidone in idiopathic pulmonary fibrosis
- (2009) H. Taniguchi et al. EUROPEAN RESPIRATORY JOURNAL
- The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis
- (2008) Effrosyni D. Manali et al. RESPIRATORY MEDICINE
- Idiopathic Pulmonary Fibrosis
- (2007) Katerina M. Antoniou et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More